Bavarian Nordic upgrades guidance following vaccine contract

Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.
Photo: Philip Davali/Ritzau Scanpix
Photo: Philip Davali/Ritzau Scanpix
by christian bundgaard, translated by daniel pedersen

A smaller outbreak of monkeypox is being documented across the world, as several countries, including the US and some in Europe, have continued to report new cases of the viral infection.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading